Poster Presentation

Paper ID : 1206-SSRC

فارغ التحصیل مقطع کارشناسی ارشد دانشگاه شهرکرد

Neuroimaging is the use of quantitative (computational) techniques to study the structure and function of the central nervous system, developed as an objective way of scientifically studying the healthy human brain in a non-invasive manner. In addition to diagnosing disease and assessing brain health, neuroimaging also studies: How the brain works and how various activities impact the brain. In recent years, neuroimaging has developed rapidly and become a powerful tool for medical research and diagnosis. With the increasing prevalence of neurological diseases, higher requirements have been put forward for neuroimaging technology and subsequent data analysis and many advances have been made in this field. Parkinson’s disease is viewed as a slowly progressive neurodegenerative disorder that begins years before diagnosis can be made, implicates multiple neuroanatomical areas, results from a combination of genetic and environmental factors and manifests with a broad range of symptoms. According to research published in Neurology, a new MRI approach can detect people in the early stages of Parkinson's disease with 85 percent accuracy. In addition to diagnosing the disease, preventing and controlling the problem is equally important. Hence, the benefits of exercise can also be presented in neurodegenerative diseases. It also represents a viable low-cost, low-risk, individualized and widely available effective non-pharmacological treatment option in cognitive decline. Physical activity can affect neurological disease symptoms by essential in delaying progressive loss of mobility and is a cost-effective intervention for fall prevention. The purpose is to review types of neuroimaging in diagnosing Parkinson’s disease and whether physical activity can affect this disease.

Parkinson'; s disease, Neuroimaging, Positron Emission Tomography (PET), Single Photon Emission Computed Tomography (SPECT), Physical activity